Yukinori Minoshima

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 5

Top Topics

Vascular Endothelial Growth Factor

Top Venues

Cancer research communications

Journal of thyroid research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jason W-L Eng, Yu Kato, Yusuke Adachi, Bhairavi Swaminathan, L A Naiche, Rahul Vadakath, Yoshimasa Sakamoto, Youya Nakazawa, Sho Tachino, Ken Ito, Takanori Abe, Yukinori Minoshima, Kana Hoshino-Negishi, Hideaki Ogasawara, Tomomi Kawakatsu, Miyuki Nishimura, Masahiko Katayama, Masashi Shimizu, Kazuhiro Tahara, Toshitaka Sato, Katsuhisa Suzuki, Kishan Agarwala, Masao Iwata, Kenichi Nomoto, Yoichi Ozawa, Toshio Imai, Yasuhiro Funahashi, Junji Matsui, Jan K Kitajewski
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium. Cancer research communications 4 (7) (2024)
Jason W-L Eng, Yu Kato, Yusuke Adachi, Bhairavi Swaminathan, L A Naiche, Rahul Vadakath, Yoshimasa Sakamoto, Youya Nakazawa, Sho Tachino, Ken Ito, Takanori Abe, Yukinori Minoshima, Kana Hoshino-Negishi, Hideaki Ogasawara, Tomomi Kawakatsu, Miyuki Nishimura, Masahiko Katayama, Masashi Shimizu, Kazuhiro Tahara, Toshitaka Sato, Katsuhisa Suzuki, Kishan Agarwala, Masao Iwata, Kenichi Nomoto, Yoichi Ozawa, Toshio Imai, Yasuhiro Funahashi, Junji Matsui, Jan K Kitajewski
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium. Cancer research communications 4 (7) (2024)
Jason W-L Eng, Yu Kato, Yusuke Adachi, Bhairavi Swaminathan, L A Naiche, Rahul Vadakath, Yoshimasa Sakamoto, Youya Nakazawa, Sho Tachino, Ken Ito, Takanori Abe, Yukinori Minoshima, Kana Hoshino-Negishi, Hideaki Ogasawara, Tomomi Kawakatsu, Miyuki Nishimura, Masahiko Katayama, Masashi Shimizu, Kazuhiro Tahara, Toshitaka Sato, Katsuhisa Suzuki, Kishan Agarwala, Masao Iwata, Kenichi Nomoto, Yoichi Ozawa, Toshio Imai, Yasuhiro Funahashi, Junji Matsui, Jan K Kitajewski
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium. Cancer research communications 4 (7) (2024)
Jason W-L Eng, Yu Kato, Yusuke Adachi, Bhairavi Swaminathan, L A Naiche, Rahul Vadakath, Yoshimasa Sakamoto, Youya Nakazawa, Sho Tachino, Ken Ito, Takanori Abe, Yukinori Minoshima, Kana Hoshino-Negishi, Hideaki Ogasawara, Tomomi Kawakatsu, Miyuki Nishimura, Masahiko Katayama, Masashi Shimizu, Kazuhiro Tahara, Toshitaka Sato, Katsuhisa Suzuki, Kishan Agarwala, Masao Iwata, Kenichi Nomoto, Yoichi Ozawa, Toshio Imai, Yasuhiro Funahashi, Junji Matsui, Jan K Kitajewski
Inhibition of Notch4 using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium. Cancer research communications (2024)
Yuki Niwa, Keito Adachi, Kimiyo Tabata, Ryoga Ishida, Koichiro Hotta, Tomomi Ishida, Yuji Mano, Yoichi Ozawa, Yukinori Minoshima, Yasuhiro Funahashi, Taro Semba
Liposome-encapsulated eribulin shows enhanced antitumor activity over eribulin for combination therapy with anti-PD-1 antibody. Molecular cancer therapeutics (2023)
Osamu Tohyama, Junji Matsui, Kotaro Kodama, Naoko Hata-Sugi, Takayuki Kimura, Kiyoshi Okamoto, Yukinori Minoshima, Masao Iwata, Yasuhiro Funahashi
Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models. Journal of thyroid research 2014 (2014)